Systemic adoptive T-cell immunotherapy in recurrent and metastatic carcinoma of the head and neck: a phase 1 study.
To, W C
Systemic adoptive T-cell immunotherapy in recurrent and metastatic carcinoma of the head and neck: a phase 1 study. [electronic resource] - Archives of otolaryngology--head & neck surgery Oct 2000 - 1225-31 p. digital
Publication Type: Case Reports; Clinical Trial; Clinical Trial, Phase I; Journal Article
0886-4470
10.1001/archotol.126.10.1225 doi
Adult
Aged
Carcinoma, Squamous Cell--therapy
Female
Granulocyte-Macrophage Colony-Stimulating Factor--administration & dosage
Head and Neck Neoplasms--therapy
Humans
Immunotherapy, Adoptive--methods
Male
Middle Aged
Neoplasm Metastasis
Neoplasm Recurrence, Local
T-Lymphocytes--immunology
Treatment Outcome
Systemic adoptive T-cell immunotherapy in recurrent and metastatic carcinoma of the head and neck: a phase 1 study. [electronic resource] - Archives of otolaryngology--head & neck surgery Oct 2000 - 1225-31 p. digital
Publication Type: Case Reports; Clinical Trial; Clinical Trial, Phase I; Journal Article
0886-4470
10.1001/archotol.126.10.1225 doi
Adult
Aged
Carcinoma, Squamous Cell--therapy
Female
Granulocyte-Macrophage Colony-Stimulating Factor--administration & dosage
Head and Neck Neoplasms--therapy
Humans
Immunotherapy, Adoptive--methods
Male
Middle Aged
Neoplasm Metastasis
Neoplasm Recurrence, Local
T-Lymphocytes--immunology
Treatment Outcome